News Headlines Article

Pfizer, Merck earnings beat Wall St. estimates
USA Today

Shares of Merck and Pfizer jumped in pre-market trading Tuesday after the drugmakers reported earnings that beat Wall Street estimates.

Merck said it earned net income of $2 billion, or 68 cents a share in the second quarter. That was up from $906 million, or 30 cents, in the same period a year ago.

Excluding one-time items, the pharmaceutical company earned 85 cents a share, which beat analysts’ consensus estimate of 81 cents a share, according to Thomson Reuters.